Tumor Mutational Burden–High Intrahepatic Cholangiocarcinoma Presenting with Solitary Brain Metastasis: A Case of Precision Oncology
Open Access
- 1 January 2026
- journal article
- Published by Japan Surgical Society in Surgical Case Reports
- Vol. 12 (1) , cr.25-0620
Abstract
INTRODUCTION: Brain metastasis from intrahepatic cholangiocarcinoma (ICC) is a rare condition with a poor prognosis, and no standard treatment has been established. This report aims to present a case of solitary ICC brain metastasis successfully treated with a multimodal approach guided by comprehensive genomic profiling (CGP).CASE PRESENTATION: A 64-year-old man, who had undergone a left hepatectomy for ICC 15 months prior, presented with recent memory difficulties. A brain MRI revealed a solitary 39-mm ring-enhancing mass in the left temporal lobe. The patient underwent surgical resection of the brain tumor, and histological examination confirmed the lesion was a metastasis from the primary ICC. Postoperatively, he received systemic therapy consisting of gemcitabine, cisplatin, and durvalumab. CGP on the resected brain specimen revealed a high tumor mutational burden status (23 mutations/Mb) and microsatellite stability. At the 8-month follow-up after the craniotomy, the patient remains disease-free with no signs of recurrence.CONCLUSIONS: This case suggests that an integrated approach, combining aggressive local therapy with systemic immunotherapy informed by biomarkers, can achieve a favorable outcome in selected patients with ICC. The identification of a high tumor mutational burden was crucial in guiding treatment and supports its potential as a predictive biomarker. This precision oncology strategy may improve the poor prognosis associated with this condition.Keywords
This publication has 19 references indexed in Scilit:
- Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified AnalysisAnnals of Surgical Oncology, 2020
- Intrahepatic CholangiocarcinomaSurgical Oncology Clinics of North America, 2019
- PD-L1 and Emerging Biomarkers in Immune Checkpoint Blockade TherapyThe Cancer Journal, 2018
- Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV MelanomaNew England Journal of Medicine, 2017
- Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 PatientsOncology, 2017
- CholangiocarcinomaThe Lancet, 2014
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain MetastasesJournal of Clinical Oncology, 2012
- Long-term survival after resection of mass-forming type intrahepatic cholangiocarcinoma directly infiltrating the transverse colon and sequential brain metastasis: Report of a caseSurgery Today, 2011
- Oligometastases.Journal of Clinical Oncology, 1995
- Central Nervous System Metastasis from Gallbladder CarcinomaNeurologia medico-chirurgica, 1991